MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy

  1. Melguizo, C.
  2. Prados, J.
  3. González, B.
  4. Ortiz, R.
  5. Concha, A.
  6. Alvarez, P.J.
  7. Madeddu, R.
  8. Perazzoli, G.
  9. Oliver, J.A.
  10. López, R.
  11. Rodríguez-Serrano, F.
  12. Aránega, A.
Journal:
Journal of Translational Medicine

ISSN: 1479-5876

Year of publication: 2012

Volume: 10

Issue: 1

Type: Article

DOI: 10.1186/1479-5876-10-250 GOOGLE SCHOLAR lock_openOpen access editor